A case report previously described that a patient with ovarian cancer who had pre-existing peripheral neuropathy secondary to CMT immediately developed grade 3 sensory and motor neuropathy after a single dose of carboplatin and paclitaxel.[18] Mutations in SBF2 cause Type 4B CMT, the only type of CMT with an autosomal recessive pattern of inheritance and characterized by axonal degeneration and myelin outfolding.[19]. Here, SBF2 is linked to ovarian carcinoma.